ML-355
N/A
Report date: 2025/11/26 20:00:44
NMEFirst In Class
Base Information
Drug NameML-355
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThomas Jefferson UniversityUniversity Of CaliforniaNational Institutes Of Health +[4]
China Registration ClassN/A
Develop Information
Active CompaniesCadrenal Therapeutics IncVeralox Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A